XV

Aesther Healthcare Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Business Combination

Retrieved on: 
Venerdì, Dicembre 16, 2022
Transfer, Tripura Merger Agreement, Acquisition, Pulmonary fibrosis, 100,000, Madison Avenue, Communication, Failure, Person, Ix, Lung cancer, Sale, Suite, Probability, XV, University, Mergers and acquisitions, Brain, Transaction, Name, Malaria, Attention, Proxy, Growth, Research, Investment, Risk, COVID-19, SPAC, Therapy, Risk management, Security (finance)

About Aesther Healthcare Acquisition Corp.

Key Points: 
  • About Aesther Healthcare Acquisition Corp.
    Aesther is a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
  • Its principals possess public and private market investing experience and operational knowledge to bring value added benefits to Ocean Biomedical.
  • Ocean Biomedical deploys the funding and expertise to move new therapeutic candidates efficiently from the laboratory to the clinic, to the world.
  • Neither of Ocean Biomedical or Aesther gives any assurance that Ocean Biomedical or Aesther, or the combined company, will achieve its expectations.

Surgalign Announces 100th Case Completed Utilizing its Recently Launched Cortera™ Spinal Fixation System

Retrieved on: 
Giovedì, Dicembre 15, 2022
Holo, Physician, Surgeon, Annual report, Failure, Communication, Ix, FDA, Vii, XV, MIS, Deformity, UI, Wurmlingen, Standard of care, Xi, COVID-19, Patient, Spine, Medical device, Risk management, Cortera

Surgalign received FDA 510(k) in August 2022 and Cortera and was introduced in a limited market release shortly thereafter.

Key Points: 
  • Surgalign received FDA 510(k) in August 2022 and Cortera and was introduced in a limited market release shortly thereafter.
  • In a little over three months, the Company has successfully penetrated target markets and today announced the completion of the 100th case utilizing this new flagship pedicle screw system.
  • The system boasts a feature-rich screw design that maintains a comparatively low profile and a newly designed locking mechanism.
  • Surgalign markets products throughout the United States and in approximately 50 countries worldwide through an expanding network of top independent distributors.

Surgalign™ Expands Adoption of its HOLO Portal™ Surgical Guidance System in Virginia

Retrieved on: 
Martedì, Dicembre 13, 2022
Holo, AR, Physician, Surgeon, Anatomy, Failure, Communication, Ix, FDA, Vii, XV, Percussion section, Food and Drug Administration, MD, Form 10-K, Wurmlingen, 100,000, Standard of care, AI, Xi, COVID-19, Patient, Medical device, Risk management

HOLO Portal is the world’s first surgical guidance system to incorporate AI and AR.

Key Points: 
  • HOLO Portal is the world’s first surgical guidance system to incorporate AI and AR.
  • This is the first clinical application of Surgalign’s HOLO™ AI digital health platform.
  • The HOLO Portal system uses AR to overlay the segmented AI reconstruction over the patient’s actual anatomy, providing real-time 3D visualization throughout the surgical procedure.
  • In January 2022, Surgalign received U.S. Food & Drug Administration (FDA) 510(k) clearance for use of the HOLO Portal system within lumbar spine procedures.

Aesther Healthcare Acquisition Corp. Announces Intention to Extend Period to Consummate Business Combination

Retrieved on: 
Martedì, Dicembre 13, 2022
Tripura Merger Agreement, Acquisition, Pulmonary fibrosis, 100,000, Madison Avenue, Communication, Failure, Person, Ix, Lung cancer, Sale, Suite, Probability, XV, University, Mergers and acquisitions, Brain, Transaction, Name, Malaria, Attention, Proxy, Growth, Research, Investment, Risk, COVID-19, SPAC, Therapy, Risk management, Security (finance)

About Aesther Healthcare Acquisition Corp.

Key Points: 
  • About Aesther Healthcare Acquisition Corp.
    Aesther is a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
  • Its principals possess public and private market investing experience and operational knowledge to bring value added benefits to Ocean Biomedical.
  • Neither of Ocean Biomedical or Aesther gives any assurance that Ocean Biomedical or Aesther, or the combined company, will achieve its expectations.
  • Such information with respect to Ocean Biomedical’s directors and executive officers will also be included in the proxy statement.

CNB Bank Introduces Women-Focused, Impressia Bank

Retrieved on: 
Lunedì, Dicembre 12, 2022
Acquisition, Woman, Treasury, Division, Result, Security (finance), Ix, Vii, Small business, CNB, XV, Bank, 100,000, Female, SBA, Trust, Guideline, Financial condition report, XIII, Analysis, Xi, Policy, EVP, Financial services, Omicron, Delta, COVID-19

CLEARFIELD, Pa., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Together, Michael Peduzzi, President and CEO of CNB Bank, and Angela Wilcoxson, EVP/Chief Commercial Banking Officer, have announced plans to launch a new bank division, Impressia Bank.

Key Points: 
  • CLEARFIELD, Pa., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Together, Michael Peduzzi, President and CEO of CNB Bank, and Angela Wilcoxson, EVP/Chief Commercial Banking Officer, have announced plans to launch a new bank division, Impressia Bank.
  • Designed for women by women, Impressia Bank will be a full-service banking division of CNB Bank dedicated to the professional and financial development and advancement of women business owners and women leaders.
  • With plans to launch in early 2023, Impressia Bank will be the sixth bank division of CNB Bank.
  • Impressia Bank will strive to propose solutions pertaining to credit access, financial literacy, and business development to promote and encourage the small business spirit and career development of women.”
    CNB Bank recently launched a search for the position of Division President for Impressia Bank.

Brookfield Corporation Successfully Completes Distribution of 25% Interest in its Asset Management Business

Retrieved on: 
Venerdì, Dicembre 9, 2022
Behavior, Health, Ix, Government, Disclosure, XXV, Vii, Safety, 100,000, Maintenance, Insurance, XV, Corporation, Legislation, Perception, Earthquake, Xi, COVID-19, Cryptocurrency, Risk management, Arrangement

Forward-looking statements are typically identified by words such as “expect”, “anticipate”, “believe”, “foresee”, “could”, “estimate”, “goal”, “intend”, “plan”, “seek”, “strive”, “will”, “may” and “should” and similar expressions.

Key Points: 
  • Forward-looking statements are typically identified by words such as “expect”, “anticipate”, “believe”, “foresee”, “could”, “estimate”, “goal”, “intend”, “plan”, “seek”, “strive”, “will”, “may” and “should” and similar expressions.
  • The estimates, beliefs and assumptions of the Corporation and the Manager are inherently subject to significant business, economic, competitive and other uncertainties and contingencies regarding future events and as such, are subject to change.
  • Neither the Corporation nor the Manager can give assurance that such estimates, beliefs and assumptions will prove to be correct.
  • The Corporation and the Manager disclaim any obligation or intention to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law.

Brookfield Announces Upgrade to Debt Rating

Retrieved on: 
Venerdì, Dicembre 9, 2022
Behavior, 100,000, Health, Disclosure, Government, Safety, Maintenance, Insurance, XV, Legislation, Perception, Earthquake, COVID-19, Cryptocurrency, Risk management

Forward-looking statements are typically identified by words such as “expect”, “anticipate”, “believe”, “foresee”, “could”, “estimate”, “goal”, “intend”, “plan”, “seek”, “strive”, “will”, “may” and “should” and similar expressions.

Key Points: 
  • Forward-looking statements are typically identified by words such as “expect”, “anticipate”, “believe”, “foresee”, “could”, “estimate”, “goal”, “intend”, “plan”, “seek”, “strive”, “will”, “may” and “should” and similar expressions.
  • Brookfield can give no assurance that such estimates, beliefs and assumptions will prove to be correct.
  • Other factors, risks and uncertainties not presently known to Brookfield or that Brookfield currently believes are not material could also cause actual results or events to differ materially from those expressed or implied by statements containing forward-looking information.
  • Brookfield disclaims any obligation or intention to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law.

MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders

Retrieved on: 
Giovedì, Dicembre 8, 2022
Security (finance), Address, Sale, Food and Drug Administration Amendments Act of 2007, Registration statement, CRIMINAL, Growth, Form, Tripura Merger Agreement, Register, Date, Person, XXV, Business, Proxy statement, Section 10 of the Canadian Charter of Rights and Freedoms, Name, Business architecture, Plan, XV, Prospectus, Environment, Special, Proxy, Medtech, Shareholder, Communication, Failure, 100,000, Maple Avenue/Maple Lane Historic District, Risk, Holding company, Risk management, Mergers and acquisitions

New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or the “Company”) today announced that on December 7, 2022, it convened and then adjourned, without conducting other business, its special meeting of stockholders (the “Special Meeting”) in lieu of its 2022 Annual Meeting of Stockholders from December 7, 2022 to 11:00 a.m. Eastern Time on December 12, 2022. The Special Meeting is being adjourned in order to solicit more votes toward the approval to amend the Company’s amended and restated certificate of incorporation (“Extension Amendment”) to extend the date by which the Company must complete a business combination from December 22, 2022 to June 22, 2023 (or such earlier date as determined by the Board of Directors). The Company plans to continue to solicit proxies for the Special Meeting until December 12, 2022.

Key Points: 
  • New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or the “Company”) today announced that on December 7, 2022, it convened and then adjourned, without conducting other business, its special meeting of stockholders (the “Special Meeting”) in lieu of its 2022 Annual Meeting of Stockholders from December 7, 2022 to 11:00 a.m. Eastern Time on December 12, 2022.
  • The Company plans to continue to solicit proxies for the Special Meeting until December 12, 2022.
  • The record date for the Special Meeting remains the close of business on October 24, 2022 (the “Record Date”).
  • Stockholders who have previously submitted their proxy or otherwise voted and who do not want to change their vote need not take any action.

Larry Doyle Joins Sompo International as Chief Operating Officer, Global Markets, Commercial P&C

Retrieved on: 
Giovedì, Dicembre 8, 2022
AIG, Geography, Commercial, International finance, Sompo Japan Nipponkoa Insurance, XV, GPW, Growth, Superior, Financial services, Management

PEMBROKE, Bermuda, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Sompo International, a leading global provider of commercial and consumer property and casualty (re)insurance, announced today that Mr. Lawrence Doyle has been appointed Chief Operating Officer (COO), Global Markets, reporting to Mr. Julian James, Sompo International’s CEO, Global Markets, Commercial P&C.

Key Points: 
  • PEMBROKE, Bermuda, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Sompo International, a leading global provider of commercial and consumer property and casualty (re)insurance, announced today that Mr. Lawrence Doyle has been appointed Chief Operating Officer (COO), Global Markets, reporting to Mr. Julian James, Sompo International’s CEO, Global Markets, Commercial P&C.
  • “I’m delighted to welcome Larry to the Sompo International Global Markets team at such a pivotal moment in our growth,” said Mr. James.
  • Sompo International refers to Sompo International Holdings Ltd., a Bermuda-based holding company, together with its consolidated subsidiaries.
  • Sompo International Holdings, Ltd. is an indirect wholly owned subsidiary of Sompo Holdings, Inc. (“Sompo Holdings”).

Brookfield Announces 2023 Dividend for the Manager and Corporation

Retrieved on: 
Mercoledì, Dicembre 7, 2022
Behavior, 100,000, Health, Disclosure, Government, Safety, Maintenance, Insurance, XV, Corporation, Legislation, Perception, Earthquake, COVID-19, Risk management, Arrangement

Forward-looking statements are typically identified by words such as “expect”, “anticipate”, “believe”, “foresee”, “could”, “estimate”, “goal”, “intend”, “plan”, “seek”, “strive”, “will”, “may” and “should” and similar expressions.

Key Points: 
  • Forward-looking statements are typically identified by words such as “expect”, “anticipate”, “believe”, “foresee”, “could”, “estimate”, “goal”, “intend”, “plan”, “seek”, “strive”, “will”, “may” and “should” and similar expressions.
  • Brookfield and the Manager can give no assurance that such estimates, beliefs and assumptions will prove to be correct.
  • Other factors, risks and uncertainties not presently known to Brookfield and the Manager or that Brookfield and the Manager currently believe are not material could also cause actual results or events to differ materially from those expressed or implied by statements containing forward-looking information.
  • Brookfield and the Manager disclaim any obligation or intention to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law.